An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

Declining cytoreductive surgery in advanced EOC is associated with significantly poorer survival outcomes compared to those who undergo the procedure. Sociodemographic factors, including race, age ...

Introduction: The use of transvaginal ultrasound-guided follicle aspiration (TVA) for oocyte collection has become a widely used procedure in horses for in vitro embryo production (IVEP). The TVA ...

The University of Cincinnati Cancer Center's Thomas Herzog, MD, the study's first author, said epithelial ovarian cancer often initially responds to chemotherapy treatment and then enters a period ...

A new cancer treatment that uses ultrasound and bubbles is set to go on trial later this year. The National Cancer Centre and the National University Cancer Institute in Singapore will start with ...

Before Tiffany Vobr was diagnosed with stage three ovarian cancer, she was very active in the Special Olympics. “When she got back from Rapid City from a state bowling tournament for the Special ...

Joss Cook found herself with all the key symptoms of ovarian cancer before she was diagnosed in 2021 In early 2021 Joss Cook began suffering from abdominal pains, bloating, needed to urinate more ...

Joss Cook found herself with all the key symptoms of ovarian cancer before she was diagnosed in 2021 [Joss Cook] ...

So there are multiple avenues to harness ultrasound for Alzheimer’s that are worth investigating further. I’ve heard that a similar approach can also be used for more targeted cancer treatments?

"Here's How I Knew I Had Uterine Cancer": One Patient's Story After Spotting a Tell ... At my annual gynecologist appointment, I brought it up. My doctor ordered a transvaginal ultrasound, but that ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli Lilly castoff solely on endometrial cancer. The Watertown, Massachusetts ...

“We need to define the role of risk-reduction surgery in reducing tubo-ovarian cancer risk for non-BRCA gene mutations to balance the benefit of cancer risk reduction with the risks associated ...